Skip to main content
Bill Grossman, MD, Internal Medicine, Fall River, MA

BillJ.GrossmanMD

Internal Medicine • Fall River, MA

Hospital Medicine/Hospitalist

Physician

Join to view full profile

Dr. Grossman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Grossman's full profile

Already have an account?

  • Office

    277 Pleasant Street
    Prima Care, Pc
    Fall River, MA 02721
    Phone+1 508-676-3292
    Fax+1 508-539-6134

Summary

  • Dr. Bill Grossman is an internist in Fall River, MA and is affiliated with Southcoast Hospitals Group. He received his medical degree from Medical College of Wisconsin in 1986 and has been in practice 36 years. He specializes in hospital medicine/hospitalist. He has 1 publication.

Education & Training

  • Scripps Mercy Hospital
    Scripps Mercy HospitalResidency, Internal Medicine, 1986 - 1989
  • Medical College of Wisconsin
    Medical College of WisconsinClass of 1986

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - Present
  • OR State Medical License
    OR State Medical License 1991 - Present
  • MA State Medical License
    MA State Medical License 1997 - 2026
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

Books/Book Chapters

  • The Cape Cod Diet and Fitness Program 
    Bill J Grossman, MD

Press Mentions

  • Gilead and Kite Oncology to Showcase Advances Across the Pipeline Aiming to Address Unmet Needs in Cancer Care at ASCO 2023
    Gilead and Kite Oncology to Showcase Advances Across the Pipeline Aiming to Address Unmet Needs in Cancer Care at ASCO 2023May 17th, 2023
  • European Medicines Agency Validates Marketing Authorization Application for Trodelvy® (Sacituzumab Govitecan-Hziy) for Pre-Treated HR+/HER2- Metastatic Breast Cancer
    European Medicines Agency Validates Marketing Authorization Application for Trodelvy® (Sacituzumab Govitecan-Hziy) for Pre-Treated HR+/HER2- Metastatic Breast CancerJanuary 3rd, 2023
  • New Data for Trodelvy Demonstrate Clinical Efficacy Across Trop-2 Expression Levels in HR+/HER2- Metastatic Breast Cancer
    New Data for Trodelvy Demonstrate Clinical Efficacy Across Trop-2 Expression Levels in HR+/HER2- Metastatic Breast CancerDecember 6th, 2022
  • Join now to see all

Professional Memberships

Dr. Bill Grossman, Dr. Bill Grossman, MD, Dr. B Grossman, Dr. Bill J. Grossman